Rising incidence of diabetic retinopathy around the globe will be the key factor driving the global “diabetic retinopathy treatment market growth”. According to the research conducted on vision loss in 2017 under the Global Burden of Disease Study, diabetic retinopathy caused visual impairment in 2.6 million people worldwide. By 2020, this number is expected to rise to 3.2 million. Diabetic retinopathy is one of the most common microvascular disorder caused by diabetes mellitus. Increasing prevalence of diabetes will further accelerate the spread of this complication.
The International Diabetes Federation estimates that approximately 463 million people the world over are suffering from diabetes currently and this number will almost double to reach 700 million by 2045. This steadily climbing rate of this chronic disease will augment the diabetic retinopathy treatment market size during the forecast period.
The report covers:
- Global Diabetic Retinopathy Treatment Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/diabetic-retinopathy-treatment-market-101153
Leading Players operating in the Diabetic Retinopathy Treatment Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Regeneron Pharmaceuticals, Inc.
- Oxurion NV
- Novartis AG
- Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Alimera Sciences
- Bayer AG
Well-Established Healthcare Infrastructure to Fuel the Market in North America
Among regions, North America is anticipated to dominate the diabetic retinopathy treatment market share owing to a robust healthcare and insurance system which ensures that patients have uninterrupted access to high-quality medical facilities. Furthermore, the market is foreseen to rise at an impressive rate owing to the increasing incidence of diabetes in the region. On the other hand, Asia-Pacific will exhibit the fastest growth rate owing to the evolving healthcare systems and increasing disposable income in the region.
Availability of Advanced Treatment Options to Boost Market Prospects
Diabetic retinopathy is an affliction which occurs when a person’s blood vessels in the retina get damaged due to high blood sugar level. It is a common condition faced by diabetics and intensive research has led to the development of excellent therapeutic options for patients. For example, in case of severe diabetic maculopathy, anti-VEGF injections are administered directly into the eyes to prevent the formation of new blood vessels in the back of the eyes. Similarly, to treat advanced stages of diabetic retinopathy, laser treatment is available which can repair the damaged blood vessels in the eyes. The procedure takes up only 40 to 50 minutes and the patient need not stay in the hospital overnight, thus saving her additional costs. The introduction of these easy-to-access and relatively affordable treatments is expected to be one of the leading diabetic retinopathy treatment market trends in the near future.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/diabetic-retinopathy-treatment-market-101153
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Diabetic Retinopathy Treatment Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Diabetic Retinopathy Treatment Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
More Trending Topics from Fortune Business Insights:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245